1493 related articles for article (PubMed ID: 26044254)
1. Clinical management and prevention of sudden cardiac death.
Yousuf O; Chrispin J; Tomaselli GF; Berger RD
Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
[TBL] [Abstract][Full Text] [Related]
2. [Non-pharmacologic prevention of sudden cardiac death].
Jurkovicová O; Cagán S
Bratisl Lek Listy; 1997; 98(7-8):423-39. PubMed ID: 9471337
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
[TBL] [Abstract][Full Text] [Related]
4. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
5. [Sudden cardiac death : Epidemiology, pathophysiology and risk stratification].
Rudic B; Tülümen E; Liebe V; Kuschyk J; Akin I; Borggrefe M
Herz; 2017 Apr; 42(2):123-131. PubMed ID: 28229201
[TBL] [Abstract][Full Text] [Related]
6. Implantable device therapy.
Goldenberg I; Moss AJ
Prog Cardiovasc Dis; 2008; 50(6):449-74. PubMed ID: 18474287
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
Klein HU; Goldenberg I; Moss AJ
Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
[TBL] [Abstract][Full Text] [Related]
8. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
Silka MJ; Kron J; Dunnigan A; Dick M
Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
[TBL] [Abstract][Full Text] [Related]
9. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
10. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
Hilleman DE; Bauman AL
Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
[TBL] [Abstract][Full Text] [Related]
11. Newer Indications for ICD and CRT.
Merriam JA; Rajendra AB; Gold MR
Cardiol Clin; 2014 May; 32(2):181-90. PubMed ID: 24793795
[TBL] [Abstract][Full Text] [Related]
12. Can we predict sudden cardiac death in long-term survivors of atrial switch surgery for transposition of the great arteries?
Wheeler M; Grigg L; Zentner D
Congenit Heart Dis; 2014; 9(4):326-32. PubMed ID: 24151816
[TBL] [Abstract][Full Text] [Related]
13. Sudden cardiac death and implantable cardioverter-defibrillators.
Turakhia MP
Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
[TBL] [Abstract][Full Text] [Related]
14. Current challenges in sudden cardiac death prevention.
Corrado D; Zorzi A; Vanoli E; Gronda E
Heart Fail Rev; 2020 Jan; 25(1):99-106. PubMed ID: 31346843
[TBL] [Abstract][Full Text] [Related]
15. Appropriate therapies predict long-term mortality in primary and secondary prevention of sudden cardiac death.
Stabile G; D'Agostino C; Gallo P; Marrazzo N; Iuliano A; De Simone A; Turco P; Palella M; Donnici G; Ciardiello C; Napolitano G; Solimene F
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):110-3. PubMed ID: 22367567
[TBL] [Abstract][Full Text] [Related]
16. Ventricular arrhythmias and sudden cardiac death: an insight from recent multicenter randomized clinical trials.
Akiyama T
Keio J Med; 1996 Dec; 45(4):313-7. PubMed ID: 9023449
[TBL] [Abstract][Full Text] [Related]
17. Ventricular tachycardia and sudden cardiac death.
Reddy PC; Tandon N; Stafford PR
J La State Med Soc; 1999 May; 151(5):281-7. PubMed ID: 10363484
[TBL] [Abstract][Full Text] [Related]
18. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
[TBL] [Abstract][Full Text] [Related]
19. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
20. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
